Niagen Bioscience
Yahoo Finance • 17 days ago
Discover September 2025's Stocks That May Be Trading Below Estimated Value
As of September 2025, the U.S. stock market is experiencing a mixed performance, with the S&P 500 and Nasdaq reaching new closing highs while the Dow Jones Industrial Average sees a decline ahead of key inflation data releases. In this env... Full story
Yahoo Finance • 24 days ago
Byrna Technologies And 2 Other Stocks That May Be Undervalued By The Market
In recent trading, the U.S. stock market has shown mixed performance with the S&P 500 and Nasdaq rising, driven by tech stocks like Alphabet reaching record highs, while the Dow Jones Industrial Average faced slight declines. As Treasury y... Full story
Yahoo Finance • 30 days ago
Three Stocks That May Be Undervalued In August 2025
As of late August 2025, the U.S. stock market is experiencing a period of optimism, with major indices like the S&P 500 and Dow Jones Industrial Average reaching record highs. Amid this bullish environment, identifying undervalued stocks c... Full story
Yahoo Finance • last month
3 Undervalued Stocks Estimated To Be 33.1% To 39.9% Below Intrinsic Value
As the U.S. stock market experiences fluctuations with tech stocks sliding and retailers in focus amid a slew of earnings reports, investors are keenly watching for insights from Federal Reserve Chair Jerome Powell's upcoming speech. In su... Full story
Yahoo Finance • last month
3 Stocks Estimated To Be Trading At Discounts Of Up To 46%
As the U.S. stock market experiences a mix of highs and lows, with the Dow Jones Industrial Average touching record levels while the S&P 500 and Nasdaq face declines, investors are keenly observing potential shifts in monetary policy and e... Full story
Yahoo Finance • last month
3 Stocks Estimated To Be Trading Up To 40.8% Below Their Intrinsic Value
As the U.S. stock market navigates a landscape marked by record highs and fluctuating inflation expectations, investors are keenly observing economic indicators that could influence Federal Reserve policy decisions. In this environment, id... Full story
Yahoo Finance • 2 months ago
Niagen Bioscience GAAP EPS of $0.04 beats by $0.03, revenue of $31.12M beats by $2.81M
* Niagen Bioscience press release [https://seekingalpha.com/pr/20191826-niagen-bioscience-inc-reports-second-quarter-2025-financial-results-and-increases-full-year] (NASDAQ:NAGE [https://seekingalpha.com/symbol/NAGE]): Q2 GAAP EPS of $0.... Full story
Yahoo Finance • 2 months ago
Stay updated with the stocks that are on the move in today's after-hours session.
The regular session of the US market on Wednesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements. [postmarket] AFTER HOURS GAINERS TICKER CHA... Full story
Yahoo Finance • 3 months ago
Niagen Bioscience secures exclusive rights for Parkinson's treatment
LOS ANGELES - Niagen Bioscience, Inc. (NASDAQ:NAGE), whose stock has surged nearly 400% over the past year according to InvestingPro data, has entered into a worldwide exclusive commercial license agreement with Norway’s Haukeland Universi... Full story
